These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38372872)

  • 1. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
    Foret T; Dufrost V; Lagrange J; Costa P; Mourey G; Lecompte T; Magy-Bertrand N; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2024 May; 26(5):178-187. PubMed ID: 38372872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
    Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
    J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation in antiphospholipid syndrome.
    Zuily S; Ait Aissa K; Membre A; Regnault V; Lecompte T; Wahl D
    Lupus; 2012 Jun; 21(7):758-60. PubMed ID: 22635224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.
    Bradáčová P; Slavík L; Skoumalová A; Úlehlová J; Kriegová E; Manukyan G; Friedecký D; Piskláková B; Ullrychová J; Procházková J; Hluší A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study.
    Zuily S; de Laat B; Guillemin F; Kelchtermans H; Magy-Bertrand N; Desmurs-Clavel H; Lambert M; Poindron V; de Maistre E; Dufrost V; Risse J; Shums Z; Norman GL; de Groot PG; Lacolley P; Lecompte T; Regnault V; Wahl D
    J Appl Lab Med; 2020 Nov; 5(6):1242-1252. PubMed ID: 32572467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Mowinckel MC; Wisløff F
    J Thromb Haemost; 2007 Nov; 5(11):2204-10. PubMed ID: 17958739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies.
    Billoir P; Miranda S; Damian L; Richard V; Benhamou Y; Le Cam Duchez V
    Thromb Res; 2018 Sep; 169():87-92. PubMed ID: 30031291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance.
    Foret T; Dufrost V; Salomon du Mont L; Costa P; Lakomy C; Lagrange J; Lacolley P; Regnault V; Zuily S; Wahl D
    Rheumatology (Oxford); 2022 Jul; 61(7):2993-2998. PubMed ID: 34791113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies.
    Radin M; Barinotti A; Cecchi I; Foddai SG; Rubini E; Roccatello D; Menegatti E; Sciascia S
    J Clin Pathol; 2023 Dec; 76(12):839-846. PubMed ID: 36100400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance.
    Pontara E; Cattini MG; Bison E; Cheng C; Denas G; Pengo V
    Thromb Res; 2022 Oct; 218():17-23. PubMed ID: 35973396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of immune/clotting assays relate to multiple antiphospholipid antibody positivity in thrombotic primary antiphospholipid syndrome.
    Ames PRJ; Merashli M; Tommaso B; Iannaccone L; Marottoli V; Ciampa A
    Int J Hematol; 2021 Feb; 113(2):183-189. PubMed ID: 33030632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system.
    Wahl D; Membre A; Perret-Guillaume C; Regnault V; Lecompte T
    Curr Rheumatol Rep; 2009 Feb; 11(1):77-81. PubMed ID: 19171115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
    Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.